Mission

ICER's mission is to lead innovation in comparative effectiveness research through methods that integrate considerations of clinical benefit and economic value.  Through a unique collaboration with patients, clinicians, manufacturers, insurers and other healthcare stakeholders, ICER develops tools to support patient decisions and medical policy that share the goal of achieving maximum value for every healthcare dollar.

Staff Only

Remember Me
TwitterLinkedinFacebookFeed
ICER's work on low-risk prostate cancer highlighted at ACMQ Annual Meeting
 
Laura Pizzi, PharmD, MPH and Donald Casey, MD, MBA, MPH presented ICER's work from its summary report on management options for low-risk prostate cancer at the 2010 American College of Medical Quality Annual Meeting.  Information from the report served as a model for decision making for patients with localized prostate cancer.  Kent Bottles, MD also presented ICER's work on prostate cancer as part of a presentation on utilizing comparative effective research.